329 related articles for article (PubMed ID: 34570454)
1. Therapeutic Response Assessment of High-Grade Gliomas During Early-Phase Drug Development in the Era of Molecular and Immunotherapies.
Ellingson BM; Wen PY; Cloughesy TF
Cancer J; 2021 Sep-Oct 01; 27(5):395-403. PubMed ID: 34570454
[TBL] [Abstract][Full Text] [Related]
2. Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.
Chen R; Cohen AL; Colman H
Curr Treat Options Oncol; 2016 Aug; 17(8):42. PubMed ID: 27334978
[TBL] [Abstract][Full Text] [Related]
3. Medical treatment of high grade malignant gliomas in adults: an overview.
Brandes A; Soesan M; Fiorentino MV
Anticancer Res; 1991; 11(2):719-27. PubMed ID: 2064325
[TBL] [Abstract][Full Text] [Related]
4. Advances in the treatment of malignant gliomas.
Khasraw M; Lassman AB
Curr Oncol Rep; 2010 Jan; 12(1):26-33. PubMed ID: 20425605
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy in glioma.
Taal W; Bromberg JE; van den Bent MJ
CNS Oncol; 2015; 4(3):179-92. PubMed ID: 25906059
[TBL] [Abstract][Full Text] [Related]
6. Novel chemotherapeutics and other therapies for treating high-grade glioma.
Kang JH; Adamson C
Expert Opin Investig Drugs; 2015; 24(10):1361-79. PubMed ID: 26289791
[TBL] [Abstract][Full Text] [Related]
7. Clinical Targeting of Altered Metabolism in High-Grade Glioma.
Scott AJ; Lyssiotis CA; Wahl DR
Cancer J; 2021 Sep-Oct 01; 27(5):386-394. PubMed ID: 34570453
[TBL] [Abstract][Full Text] [Related]
8. Advances in antibody-based drugs and their delivery through the blood-brain barrier for targeted therapy and immunotherapy of gliomas.
Huang X; Shi S; Wang H; Zhao T; Wang Y; Huang S; Su Y; Zhao C; Yang M
Int Immunopharmacol; 2023 Apr; 117():109990. PubMed ID: 37012874
[TBL] [Abstract][Full Text] [Related]
9. High-grade Gliomas.
Nayak L; Reardon DA
Continuum (Minneap Minn); 2017 Dec; 23(6, Neuro-oncology):1548-1563. PubMed ID: 29200110
[TBL] [Abstract][Full Text] [Related]
10. Concepts for Immunotherapies in Gliomas.
Platten M; Reardon DA
Semin Neurol; 2018 Feb; 38(1):62-72. PubMed ID: 29548053
[TBL] [Abstract][Full Text] [Related]
11. Arguments against the routine use of currently available adjuvant chemotherapy in high-grade gliomas.
Grossman SA
Semin Oncol; 2003 Dec; 30(6 Suppl 19):19-22. PubMed ID: 14765380
[TBL] [Abstract][Full Text] [Related]
12. Promising new therapies for malignant gliomas.
Fine HA
Cancer J; 2007; 13(6):349-54. PubMed ID: 18032970
[TBL] [Abstract][Full Text] [Related]
13. Role of tyrosine kinase inhibitors in the management of high-grade gliomas.
Ahluwalia MS; Patel M; Peereboom DM
Expert Rev Anticancer Ther; 2011 Nov; 11(11):1739-48. PubMed ID: 22050023
[TBL] [Abstract][Full Text] [Related]
14. Investigational new drugs for brain cancer.
Staedtke V; Bai RY; Laterra J
Expert Opin Investig Drugs; 2016 Aug; 25(8):937-56. PubMed ID: 27170161
[TBL] [Abstract][Full Text] [Related]
15. Improving outcomes for neurofibromatosis 1-associated brain tumors.
Brossier NM; Gutmann DH
Expert Rev Anticancer Ther; 2015 Apr; 15(4):415-23. PubMed ID: 25652347
[TBL] [Abstract][Full Text] [Related]
16. New treatment strategies for malignant gliomas.
Sathornsumetee S; Rich JN
Expert Rev Anticancer Ther; 2006 Jul; 6(7):1087-104. PubMed ID: 16831080
[TBL] [Abstract][Full Text] [Related]
17. Immunometabolism, a new therapeutic development for immunotherapies of high-grade gliomas: a narrative review.
Wu JY; Ren AL; Lim M
Chin Clin Oncol; 2022 Aug; 11(4):26. PubMed ID: 36098097
[TBL] [Abstract][Full Text] [Related]
18. Current and future directions for Phase II trials in high-grade glioma.
Alexander BM; Lee EQ; Reardon DA; Wen PY
Expert Rev Neurother; 2013 Apr; 13(4):369-87. PubMed ID: 23545053
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy for malignant gliomas.
Kyritsis AP
Oncology (Williston Park); 1993 Sep; 7(9):93-100; discussion 103, 106. PubMed ID: 8217533
[TBL] [Abstract][Full Text] [Related]
20. [The Role of Chemotherapy in the Treatment of Low-grade Gliomas].
Lakomý R; Kazda T; Poprach A; Pospíšil P; Jančálek R; Šlampa P
Klin Onkol; 2017; 30(5):343-348. PubMed ID: 29031036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
